Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Cytocom Logo
Cytocom Growth Score
53
CB Rank
47898
Heat Score
51
Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.
Founded
obfuscation
PublicPost-IPO Equity Fort Collins, Colorado, United States11-50 www.cytocom.com
Biopharma
Biotechnology
Health Care
Overview

Cytocom
Total Funding
obfuscation
Growth Score
53
Heat Score
51

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score53
-3 pts
in past quarter
Heat Score 51
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Cytocom

CB Rank
47898
Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.
Founded
obfuscation
PublicPost-IPO Equity Fort Collins, Colorado, United States11-50 www.cytocom.com
Biopharma
Biotechnology
Health Care

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Cytocom, Inc.
Operating Status Active
Stock Symbol  NASDAQ:CBLI
Company Type For Profit
Founders  Noreen Griffin
About the Company

Cytocom, Inc. a specialty biotech company, founded by patients, specializing in repurposing of drugs that deploys their patented therapies focused on the activation and rebalancing of the body’s immune system. Stimulating the body’s immune system remains one of the most promising approaches in the treatment of Cancers, HIV, Autoimmune Diseases,

inflammatory conditions and other chronic infectious diseases.

Phone Number 1-888-629-4155
Contact Email info@cytocom.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Products & Services

CYTO-200 Noroxymorphone Platform
Noroxymorphone analogs developed to target cancer, inflammatory, autoimmune, and infectious diseases.
CYTO-400 Proenkephalin Platform
Proenkephalin analogs developed to target multiple receptors associated with cancer, inflammatory, autoimmune, and infectious diseases.

Research & Development

Cytocom is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Cytocom Logo
Post-IPO Equity - Cytocom
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Cytocom Logo
Post-IPO Equity - Cytocom
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Cytocom Logo
Post-IPO Equity - Cytocom
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Cytocom Logo
Post-IPO Equity - Cytocom
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Cytocom Logo
Post-IPO Equity - Cytocom
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Cytocom Logo
Post-IPO Equity - Cytocom
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Cytocom Logo
Post-IPO Equity - Cytocom
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Cytocom Logo
Post-IPO Equity - Cytocom
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Cytocom Logo
Post-IPO Equity - Cytocom
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity
obfuscation
Post-IPO Equity - Cytocom Logo
Post-IPO Equity - Cytocom
1
obfuscation
The Global Emerging Markets GroupPost-IPO Equity

Investors

Investments

Number of Acquisitions 2

Investment Breakdown

Number of Acquisitions 2
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 5 Board Members and Advisors 1 Contacts 4

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 5, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 16, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 5, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 31, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

285
-43.9%
 in past month

Interest Signals

TopicSurge Score
Google Cloud Logo
Google Cloud
76

Actively Used Products

11Cytocom uses 11 technology products and services including HTML5, Google Fonts, and  Vimeo, according to G2 Stack.

Active Website Tech Count

10Cytocom is actively using 10 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.
Sub-Organizations
Frequently Asked Questions

Where is Cytocom's headquarters? Cytocom is located in Fort Collins, Colorado, United States.Who invested in Cytocom? Cytocom has 3 investors including Avenue Capital Group and  Adit Ventures.When was the last funding round for Cytocom? Cytocom closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has Cytocom raised to date? Cytocom has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3f74325 1)
|